Canaccord Lowers Aspen Aerogels (ASPN) PT to $5, Cites Healthy Liquidity

Aspen Aerogels Inc. (NYSE:ASPN) is one of the best NYSE penny stocks to invest in right now. On November 7, Canaccord analyst George Gianarikas lowered the price target on Aspen Aerogels to $5 from $10  with a Buy rating on the shares. Gianarikas projects that the company’s liquidity will remain healthy due to a solid balance sheet and minimal capital expenditure needs. Looking beyond 2026, Canaccord anticipates a return to robust levels of EBITDA, which is expected to result in a material flow through to free cash flow.

Just a day prior, on November 6, Aspen Aerogels announced its financial results for Q3 2025, where the total revenue stood at $73.02 million, which was a 37.77% year-over-year decline and also a 6% sequential drop. The net loss per share reported in this quarter was $0.06.

Canaccord Lowers Aspen Aerogels (ASPN) PT to $5, Cites Healthy Liquidity

Aspen Aerogels also updated its full-year 2025 financial outlook to reflect the lower near-term EV production in North America. The updated guidance for revenue is now $270 to $280 million, down from the prior outlook of $297 to $317 million. Most significantly, the Adjusted EBITDA outlook was reduced to a range of $7 to $15 million from the prior outlook of $35 to $45 million.

Aspen Aerogels Inc. (NYSE:ASPN) is an aerogel technology company that designs, develops, manufactures, and sells aerogel materials primarily for use in the energy industry, sustainable insulation materials, and EV markets in the US, Canada, Asia, Europe, and Latin America.

While we acknowledge the potential of ASPN to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than ASPN and that has 100x upside potential, check out our report about this cheapest AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.